Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease
Authors
Keywords
-
Journal
ACS Nano
Volume 15, Issue 4, Pages 7357-7369
Publisher
American Chemical Society (ACS)
Online
2021-03-18
DOI
10.1021/acsnano.1c00658
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
- (2020) Frank de Wolf et al. BRAIN
- Blood Biomarkers: Democratizing Alzheimer’s Diagnostics
- (2020) Henrik Zetterberg et al. NEURON
- Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona
- (2020) John E. Blume et al. Nature Communications
- Nano-scavengers for blood biomarker discovery in ovarian carcinoma
- (2020) Marilena Hadjidemetriou et al. Nano Today
- Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
- (2019) Daniel A. Nation et al. NATURE MEDICINE
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
- (2019) Pierre Dourlen et al. ACTA NEUROPATHOLOGICA
- The “rights” of precision drug development for Alzheimer’s disease
- (2019) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma
- (2019) Simon Lovestone et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Molecular biomarkers of Alzheimer's disease: progress and prospects
- (2018) Tammaryn Lashley et al. Disease Models & Mechanisms
- A Blood Test for Alzheimer’s Disease: Progress, Challenges, and Recommendations
- (2018) Steven J. Kiddle et al. JOURNAL OF ALZHEIMERS DISEASE
- A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
- (2018) Liu Shi et al. JOURNAL OF ALZHEIMERS DISEASE
- Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes
- (2018) Zahraa S. Al-Ahmady et al. JOURNAL OF CONTROLLED RELEASE
- In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape
- (2018) Rafaela García-Álvarez et al. Nanoscale
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Levels of ADAM10 are reduced in Alzheimer’s disease CSF
- (2018) Aitana Sogorb-Esteve et al. Journal of Neuroinflammation
- An age-old story of dementia
- (2018) Liam Drew NATURE
- The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study
- (2018) Marilena Hadjidemetriou et al. ADVANCED MATERIALS
- A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona
- (2018) Marilena Hadjidemetriou et al. BIOMATERIALS
- A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers
- (2017) Emma Lawrence et al. JOURNAL OF ALZHEIMERS DISEASE
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
- (2017) Jun Wang et al. Nature Reviews Neurology
- On the path to 2025: understanding the Alzheimer’s disease continuum
- (2017) Paul S. Aisen et al. Alzheimers Research & Therapy
- Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles
- (2016) Marilena Hadjidemetriou et al. Nanoscale
- Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer’s disease
- (2016) Dejiang Wang et al. NEUROREPORT
- Alzheimer's disease: are blood and brain markers related? A systematic review
- (2016) Ali T. Khan et al. Annals of Clinical and Translational Neurology
- In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles
- (2015) Marilena Hadjidemetriou et al. ACS Nano
- Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
- (2015) Alison L. Baird et al. Frontiers in Neurology
- The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats
- (2014) J.R. Rivers-Auty et al. NEUROSCIENCE LETTERS
- Developing novel blood-based biomarkers for Alzheimer's disease
- (2013) Heather M. Snyder et al. Alzheimers & Dementia
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
- (2013) Stefan Tenzer et al. Nature Nanotechnology
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
- (2011) Maria I Fonseca et al. Journal of Neuroinflammation
- Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium
- (2007) Timothy R. Mhyre et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started